IBKR vs. VRNA

Last updated Jul 25, 2026

IBKR (Interactive Brokers Group, Inc.) and VRNA (Verona Pharma plc) are both stocks. IBKR operates in Capital Markets (Financial Services), while VRNA operates in Biotechnology (Healthcare). At a 0.11 correlation, their price movements are largely independent.

Performance

IBKR vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Interactive Brokers Group, Inc. (IBKR) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IBKR

• 1D: -0.02%
• 1M: -1.13%
• 6M: 18.50%
• YTD: 42.95%
• 1Y: 42.44%
• 3Y*: 65.07%
• 5Y*: 44.03%
• 10Y*: 27.43%
• ALL TIME*: 15.36%

VRNA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
IBKR Interactive Brokers Group, Inc.	$385.79M	$407.61M	$424.58M

IBKR vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IBKR Interactive Brokers Group, Inc.	42.95%	46.37%	114.43%	15.14%	-8.35%	31.12%	31.71%	-14.01%	-7.13%	70.31%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%

Correlation

The correlation between IBKR and VRNA is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.11

The correlation between IBKR and VRNA shifts across timeframes, from -0.04 (1 year) to 0.15 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap IBKR : $158.53B VRNA : $9.72B
EPS IBKR : $4.11 VRNA : -$0.69
PS Ratio IBKR : 4.57 VRNA : 57.97
PB Ratio IBKR : 1.86 VRNA : 34.92
Total Revenue (TTM) IBKR : $8.99B VRNA : $167.65M
Gross Profit (TTM) IBKR : $8.21B VRNA : $159.52M
EBITDA (TTM) IBKR : $7.25B VRNA : -$40.86M

Return for Risk

IBKR vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBKR

IBKR Risk / Return Rank: 79
IBKR Sharpe Ratio Rank: 80
IBKR Sortino Ratio Rank: 76
IBKR Omega Ratio Rank: 73
IBKR Calmar Ratio Rank: 82
IBKR Martin Ratio Rank: 82

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBKR vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Interactive Brokers Group, Inc. (IBKR) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IBKR	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	1.12	—	—
Sortino ratio: Return per unit of downside risk	1.70	—	—
Omega ratio: Gain probability vs. loss probability	1.20	—	—
Calmar ratio: Return relative to maximum drawdown	2.28	—	—
Martin ratio: Return relative to average drawdown	5.69	—	—

Drawdowns

Drawdown Indicators

	IBKR	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-63.66%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-18.70%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-38.66%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-38.66%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-55.09%	—	—
Current Drawdown Current decline from peak	-5.82%	—	—
Average Drawdown Average peak-to-trough decline	-24.72%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	7.49%	—	—

Volatility

Volatility by Period

	IBKR	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.75%	—	—
Volatility (6M) Calculated over the trailing 6-month period	28.29%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	38.17%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.85%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.40%	—	—

Dividends

IBKR vs. VRNA - Dividend Comparison

IBKR's dividend yield for the trailing twelve months is around 0.36%, while VRNA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IBKR Interactive Brokers Group, Inc.	0.36%	0.47%	0.48%	0.48%	0.55%	0.50%	0.66%	0.86%	0.73%	0.68%	1.10%	0.92%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both IBKR and VRNA in my portfolio?

IBKR and VRNA have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.